PortfoliosLab logo
CLOV vs. NU
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CLOV and NU is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

CLOV vs. NU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Nu Holdings Ltd. (NU). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

CLOV:

2.57

NU:

0.05

Sortino Ratio

CLOV:

3.36

NU:

0.39

Omega Ratio

CLOV:

1.41

NU:

1.05

Calmar Ratio

CLOV:

2.23

NU:

0.06

Martin Ratio

CLOV:

11.55

NU:

0.11

Ulcer Index

CLOV:

18.44%

NU:

19.73%

Daily Std Dev

CLOV:

80.32%

NU:

48.27%

Max Drawdown

CLOV:

-97.16%

NU:

-72.07%

Current Drawdown

CLOV:

-85.68%

NU:

-24.54%

Fundamentals

Market Cap

CLOV:

$1.63B

NU:

$57.60B

EPS

CLOV:

-$0.04

NU:

$0.44

PS Ratio

CLOV:

1.10

NU:

10.20

PB Ratio

CLOV:

4.86

NU:

6.84

Total Revenue (TTM)

CLOV:

$1.49B

NU:

$11.74B

Gross Profit (TTM)

CLOV:

$391.93M

NU:

$5.29B

EBITDA (TTM)

CLOV:

-$22.89M

NU:

$3.09B

Returns By Period

In the year-to-date period, CLOV achieves a -0.63% return, which is significantly lower than NU's 15.73% return.


CLOV

YTD

-0.63%

1M

-9.28%

6M

-8.48%

1Y

203.88%

3Y*

4.92%

5Y*

N/A

10Y*

N/A

NU

YTD

15.73%

1M

-3.38%

6M

-11.38%

1Y

2.39%

3Y*

43.83%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Clover Health Investments, Corp.

Nu Holdings Ltd.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

CLOV vs. NU — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9595
Overall Rank
The Sharpe Ratio Rank of CLOV is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9696
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9393
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9494
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9696
Martin Ratio Rank

NU
The Risk-Adjusted Performance Rank of NU is 5050
Overall Rank
The Sharpe Ratio Rank of NU is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of NU is 4747
Sortino Ratio Rank
The Omega Ratio Rank of NU is 4848
Omega Ratio Rank
The Calmar Ratio Rank of NU is 5454
Calmar Ratio Rank
The Martin Ratio Rank of NU is 5252
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CLOV vs. NU - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Nu Holdings Ltd. (NU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CLOV Sharpe Ratio is 2.57, which is higher than the NU Sharpe Ratio of 0.05. The chart below compares the historical Sharpe Ratios of CLOV and NU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

CLOV vs. NU - Dividend Comparison

Neither CLOV nor NU has paid dividends to shareholders.


TTM2024202320222021
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%2.69%
NU
Nu Holdings Ltd.
0.00%0.00%0.00%0.00%0.00%

Drawdowns

CLOV vs. NU - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.16%, which is greater than NU's maximum drawdown of -72.07%. Use the drawdown chart below to compare losses from any high point for CLOV and NU.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

CLOV vs. NU - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 18.32% compared to Nu Holdings Ltd. (NU) at 9.93%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than NU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

CLOV vs. NU - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Nu Holdings Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-1.00B0.001.00B2.00B3.00B20212022202320242025
462.33M
3.15B
(CLOV) Total Revenue
(NU) Total Revenue
Values in USD except per share items

CLOV vs. NU - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Nu Holdings Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%20212022202320242025
23.6%
40.6%
(CLOV) Gross Margin
(NU) Gross Margin
CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a gross profit of 108.89M and revenue of 462.33M. Therefore, the gross margin over that period was 23.6%.

NU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Nu Holdings Ltd. reported a gross profit of 1.28B and revenue of 3.15B. Therefore, the gross margin over that period was 40.6%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported an operating income of -1.27M and revenue of 462.33M, resulting in an operating margin of -0.3%.

NU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Nu Holdings Ltd. reported an operating income of 795.07M and revenue of 3.15B, resulting in an operating margin of 25.3%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a net income of -1.27M and revenue of 462.33M, resulting in a net margin of -0.3%.

NU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Nu Holdings Ltd. reported a net income of 557.20M and revenue of 3.15B, resulting in a net margin of 17.7%.